Infuse Bone Graft Claim Can’t Be Based On Sales Reps’ Prediction Of Approval
ST. LOUIS — Alleged statements by Medtronic Inc. sales representatives that an off-label use of its Infuse bone graft would be approved in the future is an opinion and not a...To view the full article, register now.
Already a subscriber? Click here to view full article